PT3042658T - Composição medicinal que melhora a resistência à leptina - Google Patents

Composição medicinal que melhora a resistência à leptina

Info

Publication number
PT3042658T
PT3042658T PT14843063T PT14843063T PT3042658T PT 3042658 T PT3042658 T PT 3042658T PT 14843063 T PT14843063 T PT 14843063T PT 14843063 T PT14843063 T PT 14843063T PT 3042658 T PT3042658 T PT 3042658T
Authority
PT
Portugal
Prior art keywords
medicinal composition
leptin resistance
composition improving
improving leptin
resistance
Prior art date
Application number
PT14843063T
Other languages
English (en)
Inventor
Akira C/O Kyoto University Kakizuka
Ken C/O Kyoto University Ebihara
Megumi C/O Kyoto University Abe
Chihiro C/O Kyoto University Ebihara
Original Assignee
Univ Kyoto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kyoto filed Critical Univ Kyoto
Publication of PT3042658T publication Critical patent/PT3042658T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/655Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C245/00Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
    • C07C245/02Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides
    • C07C245/06Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings
    • C07C245/10Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
PT14843063T 2013-09-04 2014-09-03 Composição medicinal que melhora a resistência à leptina PT3042658T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013183265 2013-09-04

Publications (1)

Publication Number Publication Date
PT3042658T true PT3042658T (pt) 2019-05-13

Family

ID=52628448

Family Applications (1)

Application Number Title Priority Date Filing Date
PT14843063T PT3042658T (pt) 2013-09-04 2014-09-03 Composição medicinal que melhora a resistência à leptina

Country Status (8)

Country Link
US (1) US9931351B2 (pt)
EP (1) EP3042658B1 (pt)
JP (1) JP6378685B2 (pt)
DK (1) DK3042658T3 (pt)
ES (1) ES2708577T3 (pt)
PL (1) PL3042658T3 (pt)
PT (1) PT3042658T (pt)
WO (1) WO2015033981A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210145808A1 (en) * 2018-04-16 2021-05-20 Kyoto University Composition for Protecting Cardiomyocyte
JP7101982B2 (ja) 2018-07-31 2022-07-19 国立大学法人京都大学 脳梗塞の処置用の医薬組成物
KR20220087499A (ko) 2019-10-24 2022-06-24 고쿠리츠 다이가쿠 호진 교토 다이가쿠 연골 보호용의 의약 조성물
JP2022170472A (ja) 2021-04-28 2022-11-10 国立大学法人京都大学 皮膚組織の異常を改善するための組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69332105T2 (de) 1992-09-29 2003-03-06 Inhale Therapeutic Systems San Pulmonale abgabe von aktiven fragmenten des parathormons
KR19990077319A (ko) 1996-01-17 1999-10-25 한센 핀 베네드, 안네 제헤르 축합된 1,2,4-티아디아진 및 축합된 1,4-티아진 유도체, 그것의제조방법 및 사용
WO1999003861A1 (en) 1997-07-16 1999-01-28 Novo Nordisk A/S Fused 1,2,4-thiadiazine derivatives, their preparation and use
US6440961B1 (en) * 1997-10-27 2002-08-27 Dr. Reddy's Research Foundation Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
US8273700B2 (en) * 2005-09-29 2012-09-25 The Johns Hopkins University Methods and compositions for treatment of cystic fibrosis
US9573887B2 (en) * 2010-07-30 2017-02-21 Daito Chemix Corporation Naphthalene derivative
ES2574832T3 (es) 2010-09-30 2016-06-22 Kyoto University Agente para el tratamiento de enfermedades oculares
KR101862912B1 (ko) * 2012-07-20 2018-05-30 클리브 바이오사이언스 인코포레이티드 (클리브) p97 복합체의 저해제로서의 축합된 피리미딘
US9782420B2 (en) 2013-02-20 2017-10-10 Kyoto University Method for treating eye diseases

Also Published As

Publication number Publication date
EP3042658A4 (en) 2017-03-29
DK3042658T3 (en) 2019-04-23
PL3042658T3 (pl) 2019-08-30
US20160303144A1 (en) 2016-10-20
JP6378685B2 (ja) 2018-08-22
US9931351B2 (en) 2018-04-03
ES2708577T3 (es) 2019-04-10
EP3042658A1 (en) 2016-07-13
WO2015033981A1 (ja) 2015-03-12
EP3042658B1 (en) 2019-01-16
JPWO2015033981A1 (ja) 2017-03-02

Similar Documents

Publication Publication Date Title
HK1223975A1 (zh) 含納米氣泡的組合物及其用途
HK1216175A1 (zh) 治療性化合物和組合物
IL286759A (en) Therapeutic methods and preparations
IL246377A0 (en) Pharmaceutical preparations for oral administration
EP2889350A4 (en) ADHESIVE COMPOSITION
GB201317286D0 (en) Composition and Use
HK1220920A1 (zh) 治療性組合物和其用途
HK1215191A1 (zh) 低劑量醫藥組合物
IL241254A0 (en) Pharmaceutical preparations containing everolimus
EP3006525A4 (en) ASPHALT-URETHANE COMPOSITION
HK1215678A1 (zh) 口腔用組合物
HK1225306A1 (zh) 牙科組合物
EP3066178A4 (en) GREASE COMPOSITION
SG11201601477VA (en) Pharmaceutical composition
HK1219691A1 (zh) 醫藥組成物及其用途
PT3042658T (pt) Composição medicinal que melhora a resistência à leptina
GB201301979D0 (en) New composition and use thereof
SG11201506778QA (en) Plasticizing composition
GB201308933D0 (en) Paediatric composition
EP2977051A4 (en) GINSENOSIDZUSAMMENSETZUNG
GB201301774D0 (en) Composition
HK1220143A1 (zh) 藥物組合物
EP2956112A4 (en) DENTAL COMPOSITION
GB201318813D0 (en) Dental composition
GB201304625D0 (en) New pharmaceutical composition